Reprints of Past Articles
Choose by: Topic | Title | Date of Publication Many reprints are available at NO CHARGE. If there is a fee for a reprint it is $4.95 to $9.95 with many reprints available for ONLY $6.95. Order and pay online by credit card or e-check for QUICK delivery of PDF files to you by e-mail. No subscription is required to order reprints.
Special Reports & Supplements Product/Service Reviews Editorials & Opinions NEW!
ePharma Marketing, Vol. 2
Social Media Marketing
DTC Advertising
Relationship Marketing
ePharma Marketing, Vol. 1
Physician Education
Sales Force Effectiveness
eDetailing SPECIAL!
Case Studies and Reviews featuring innovative Products and Services for Pharmaceutical Marketing and Sales. Presents Practical Solutions from leading vendors and suppliers. Mostly FREE!
OpEd pieces from Pharma Marketing News, Pharma Marketing Blog Topics, and Summaries of Surveys of experts on a variety of controversial topics in Pharmaceutical Marketing. Access Here Access Here Access Here
Choose By Topic
Choose a topic from the following list to access and order specific reprints by topic now.
KEEP IN MIND THAT MANY ARTICLES ARE AVAILABLE FREE OF CHARGE!
Use the following drop down menu to access and order specific reprints by topic now.
Select A Reprint Topic AreaProduct & Service ReviewsGlobal Pharma Marketing PracticesBrand MarketingCompliance Marketing & EducationDirect-to-Consumer (DTC) Advertising & MarketingeMarketing and ePromotionMSLs and KOL ManagementMarket ResearchOpEd and Survey Summary ReprintsPatient EducationPhysician Education (CME)Physician Marketing & PromotionRegulatory ComplianceRelationship MarketingSales Force EffectivenessStrategic Marketing & Planning
Physician Marketing, Sales, and Education
- Physician Education (CME)
- Physician Marketing & Promotion
- MSLs and KOL Management
- Sales Force Effectiveness
Consumer Marketing and Education
Marketing Techniques and Tools
- Market Research
- Customer Relationship Management (CRM)
- Brand Marketing
- Relationship Marketing
- eMarketing and ePromotion
Regulatory Compliance, Privacy and Strategy
Miscellaneous
- Product & Service Reviews — Where the rubber meets the road!
- Global Pharma Marketing Practices — Thinking outside the States!
Choose By Title
Click on a title to access the summary and from there you can view or order the full reprint.
A…
- The Absolute, Relative, and Incremental ROI of DTC e-Marketing
- Accomplishing Adherence
- Accountability for Pharma Content on Social Media Sites
- A Call to Action: A Mea Non Culpa by Big Pharma
- A Few Things I Learned at FDA’s Social Media Hearing
- A Good Time Was Had by All
- Ad Dollars Follow Eyeballs to Web
- Americans Skeptical of Pharma Cause Marketing
- An Online Community to Call Our Own
- Applying FDA Marketing Regulations to Internet Promotions
- Are Pharma Bloggers Biased Against the Industry?
- Are Sales Reps Necessary?
- Awards. What Are They Good For?
B…
- Balancing Idealistic vs. Realistic CRM Processes
- Betting the Pharm
- Beyond DTC: Consumer Relationship Satisfaction
- Beyond Patient Education: Influencing Behavior Change
- Beyond the eDetail: Evolving to Educate
- Big Pharma Sales Analytics for the Rest of Us
- Biotech DTC: Business Not As Usual
- Blogging My Way Into 2005!
- Blogs and the Pharmaceutical Industry
- Branded Physician Education: How to Integrate Promotion and Education
- Branding Internally: Think Brand, Not Product
- The Brand Marketing Mix
- Brits Beat FDA & PhRMA: Issue Social Media Guidance for Pharma
- Building a Blockbuster
- Building the “New” Pharma Physician Marketing Model
- Building the Optimal Service Model: Creating the Right Physician Experiences to Drive Business
- Building Power Sales Messages
- Buzz ‘n Blog Marketing
C…
- California’s Physician Prescribing Act: A History of Twists and Turns
- Can Health Web Sites Improve Compliance?
- Capturing & Reporting HCP-Related Meeting Spending
- cDetailing: Addressing the Consumer Education Gap
- Challenges of Regulating Mobile Medical Apps
- The Changing Pharma Commercial Model in 2010 and Beyond
- The Changing Landscape of Physician Interactions
- The Changing Policy Landscape: Prepare Now for the Coming FDA and Pharmaceutical Marketing Reforms
- The Changing Role of Pharma Sales Reps
- The Changing World of MSLs: Determining Value
- Cholesterol Drug Users Discuss Their Medication
- Closed Loop Marketing
- Closed-Loop Patient Education
- Collaborating with Online Physician Communities
- The Coming Pharma Marketing Recession
- Communicating Risk: Let the Dialog Begin
- Compliance with (Some) New ACCME Rules Not So Easy
- Congress vs. Pharma: Trouble Ahead?
- Consequences of Direct-to-Consumer Advertising
- Consumer Use of the Internet for Health: Whose Numbers Do You Believe?
- Controlling Your Brand’s Switch Destiny
- Corporate Reputation in the New Media World
- Corporate “Moral Values” Anyone?
- Cost-Cutting Strategies for the Pharma Industry
- Could Chill Kill CME?
- Creating a Successful DTC Campaign on the Inside
- Creating the Most Effective Sales Calls
- A Crisis in Professional Detailing
- Critical: What Daschle Plans to Do About the Healthcare Crisis
- Current Issues and Future Prospects for Sales Force Effectiveness
D…
- Data Mining in the Deep, Dark Social Networks of Patients
- Developing Guidelines for Pharma’s Use of the Internet & Social Media: A Call for a Public Hearing at FDA
- Developing Win-Win Key Opinion Leader Relationships
- Digital Pharma Is Alive and Well in Europe!/A>
- Direct to Physician Telemarketing and Sales
- Disease Mongering
- Disease Mongering: When Is the Line Crossed?
- Diversity in the Life Sciences
- Diversity in Pharma
- DocCheck: Das Portal
- Does the FDA Need to be Overhauled?
- Doing a Good Job but Still Not Trusted!
- Drug Reimportation Survey Results
- Drug Marketers Need More Than Demographic Data To Effectively Market To Consumers
- Drug Prices, Declining Profits Top Issues for 2005
- Drug Risk Survey Results
- DTC, for Better or Worse, is Here to Stay
- DTC in 2005: Can You Teach Old Dogs New Tricks?
- DTC Pros and Cons Presented at FDA Hearing
- DTC Risk Communication
- DTC User Fees Go PDUffft!
E…
- eDetailing Technology & Birth of “Sales Cyborg”
- eDetailing: Yesterday, Today and Tomorrow
- The End of DTC as We Have Known It
- E-mail Marketing Best Practices for Pharma
- Emotions, Focus and Storytelling: How Cialis is Challenging Viagra
- e-Marketing at the Point of Care
- Effective Pharma Adherence Programs Start With The Patient
- Effective Physician Marketing at Medical Meeting Exhibits
- e-Inertia Plagues the Pharma Industry
- The Empowered Patient: What It Means for Pharma Marketers
- The ePharma Pioneer Club™: Convincing Pharma Marketers to Engage in “e”
- ePrints NRx for Physician Detailing
- The Electronic Formulary Will Change the Equation
- Engagement
- Ethical Online Practices Build Consumer Trust
- European Compliance Not Only Possible, But Leading Edge
- The European eMarketing Scene: Desperately Seeking Strategy
- European Online Marketing Survey Results
- Evolve Your Brand into a Relationship with Consumers and Physicians
- The Evolving Impact of Anti-Spam Legislation on Online Marketers
- Eyes on the Adherence Prize/A>
- The Expanding Pharma Blogosphere
F…
- Facilitating Physician Access and Education Through Online Conferencing
- Fast Start to Customized ePromotion and eLearning Physician Programs
- FDA Can Relax. I Did All the Work for Them!
- FDA, DOJ, & Google: Conspiracy Theory, Part 2
- FDA Drops “Social Media” from Its 2011 Guidance Agenda
- FDA Draft Guidance for Print DTCA: Less than Feared
- FDA Draft Guidance on Risk: Reading the Tea Leaves
- FDA Finalizes Guidance on Distribution of Reprints
- FDA’s Bad Ad Program is “Phoniest Thing Ever!”
- FDA’s BadAd Program Lacks Credible Evidence
- FDA’s Good Reprint Practices Guidance
- FDA’s Use of Social Media: Peanuts Today, Drugs Tomorrow!
- FDA Plans to Test New Standard for Easy to Understand Rx Labels
- FDA v. Google & Those 14 Infamous Warning Letters
- Fear and Loathing in Washington, DC
- Finding the Consumer Within the Patient
- Finding the “Right Stuff” to Revitalize Sales Productivity
- First FDA Social Media Guidance to Address Responding to “Unsolicited Requests” for Off-label Information
- Free Drug Samples: The Sales Rep’s Last Great Hope?
- Free Gifts to Physicians: What’s the Big Deal?
- Free Prescription Drug Cards
- From Nalty to “Nalts”: The Transformation of a Pharma Marketing Director into a “Viral Video Genius”
- From Science to CEO: The Scientific Path to Corporate Leadership
- The FTC-Lilly Consent Decree: What it Means for PHARMA Vendors and Partners
- The Future of Big Pharma
- The Future of DTC Advertising: Is a Perfect Storm Brewing?
- The Future of eDetailing
G…
- Generation Rx: A History and Critique of Pharma “Tribal Marketing”
- Getting Market Research Right in Emerging Markets
- Getting Market Research Right in the Middle East/A>
- Give Docs What They Want
- Global Digital Asset Brand Management
- Global Pharma Competitive Intelligence
- God Bless R&D, but Marketers May Go to Hell!
- Good Promotion Practices Alliance
- Got Game? Online Pharma Advergaming
- Growing Pharmaceutical Sales Utilizing Six Sigma and Lean
- GSK Strikes Back with a Grassroots Campaign
- Guerilla Pharma Marketing
- Guidelines for Off-label Communications
H…
- Hard Sell: The Evolution of a Generation X Salesman
- Has DTC Spending Peaked?
- Healthcare Communications vs. Pharma Marketing (pdf)
- Helping Pharma eMarketing “Grow up”
- High Impact Content in Support of Rx Brands
- How Readable, Credible & Useful are Pharma Blogs?
- How to Get Your Message In Front of Pharma Brand Managers
- How to Manage the Online Conversation
- How to Sell a Drug Before it is Approved
- How Should Pharma Engage in Social Networks?: Thoughts on Best Practices
- The Hypocrisy of Healthcare Marketing Restrictions: Stand Up for Healthcare Marketing Free Speech
I…
- I’m All a Twitter Over Twitter
- The Impact of eDetailing: Will it Complement, Replace, or Become Integrated with the Sales Force?
- Implications of Facebook’s Page Commenting Changes
- Increase Prescription Sales with Smart Tools
- India’s Booming Pharmaceutical Market
- Industry and Consumer Advocates Square Off Regarding Social Media
- Innerstate: The First Disease Awareness Documentary Film
- Integrating Compliance into Commercial Practices
- Integrating Online & Offline Marketing: Challenges for Pharma
- Integration of Custom Media into the Marketing Mix
- Intelligent Online Sampling Strategies
- The Internet and CME
- Interpretation of Ads
- The iPad as a Pharma Marketing Platform
- Is It Time to End Industry Sponsored CME?
- Is Pharma Ready for HIPAA?
- Is Pharma Marketing a Lot of BS?
- Is Your Product Ready for Consumers?
- It’s All About Education
- It’s the Science, Stupid!
J…
K…
L…
- Let’s Respond to FDA’s Questions Regarding Its Regulation of Social Media
- Leverage Health Beliefs to Develop Effective Online Compliance Programs
- Limbic Market Research: Plumbing the Subconscious Motivators of Physicians
- (Little) Used Drug for Sale. GSK Says, Bye Bye Alli!
M…
- Managing Cross Boundary Issues
- Managing Medical Science Liaisons From Afar
- Managing Privacy Risks in Your Commercial Practices
- Managing Reprints for Better Clinical Support of Marketing
- Mapping New Paths through the DTC Marketing Mix Maze
- Marketing in the Post-Vioxx Era
- Marketing the Pharma Industry: The Empire Strikes Back
- Marketing’s Role in Limiting Physician Access and What to Do About It
- Maximizing the DTC Message: Healthcare Businesswomen’s Association Members Evaluate DTC Marketing
- Measuring an Intangible: Medical Science Liaison Metrics Consensus
- Measuring & Communicating eSuccess: Strategy First, YouTube Later… Maybe
- Measuring Marketing Strategy
- Measuring Consumer Sentiment About Prescription Drugs
- Medical Device Marketing
- Medical Science Liaisons: Working between Two Worlds
- Medical Transcript Advertising
- Merit of CHC Petition to FDA
- Merck Rejiggers Its Marketing Mix
- Midwestern eMarketing Values
- Mining Mobile Health App User Data
- Mobile Medical Reference: An Effective Door Opener for Sales Reps
- Mobile Pharma Marketing: What’s the 411?
- Moderation Best Practices for Pharma Social Networks
- Moore: Please Don’t Ignore Us Pharma Bloggers
- Motivating & Retaining The MSL: What Makes MSLs Tick
- Moving the Needle on Adherence
- MSL Role in Educational Development
- MSL Roles & Goals
- Murky Physician Marketing and Education Practices
N…
- A New Estimate of Drug Development Cost
- New Facebook Policy “Kind of Hurts” Pharma Marketers
- New Media Privacy Issues & Online Health Marketing
- The New PhRMA Code and Beyond: Federal & State Laws are Eclipsing Self-Regulation
- New Privacy Rules in Economic Stimulus Law: Will They Restrict Certain Pharmaceutical Marketing Practices?
- The New Rules of Marketing & PR: Book Review and Insights for Pharma
- New Social Media Regulatory Framework
- The New Written Prescription: Leveraging Technology to Measure Change in Physician Behavior as it Occurs
- No More Free Lunch in California?
- A Novel Approach to Communicating with Physicians
- Numbers
- Numbers, Math and Communicating Risk
O…
- Obama v. McCain Survey Results
- One…uh, Two Small Steps for Pharmaco Blogging!
- Online and Offline Professional and Consumer Marketing
- Online CME – A Glass Half-Full or Half-Empty?
- Optimizing Brand Equity: Pre-Launch through Patent Expiry and Beyond!
- Optimizing Market Access: A Guide to Effective Pricing, Reimbursement and Messaging Strategies
- Optimizing DTC Performance
- Optimizing eDetailing ROI
- Out-of-the-Box Marketing: Will It Work for Pharma?
- Overcoming Space Limitations in Social Media
- Owning the Prescription Pad: Driving Brand Decisions in a Multi-Influence World
P…
- Paid Inclusion: Too Hot for Pharma Marketing?
- Patient Assistance Program Rankings: Going Beyond Sales Force Effectiveness to Customer Experience Satisfaction
- Patient-Level Data: A New Level of Analysis
- Patient Detailing at the Point of Care
- Personalized e-Marketing – How can you create and profit from a customer’s lifetime experience?
- Peter Rost: Whistle Blower, Pharma Blogger, ???
- Pfizer France: Viva la SFE Difference!
- Pharma Begins to Reveal Payments to Physicians
- Pharma BloggoSphere Update
- Pharma Collaboration with Online Patient Opinion Leaders
- Pharma eMarketing: A Level Playing Field or a Killing Field?
- Pharma Even More Digitally Feeble When it Comes to Healthcare Providers
- Pharma Marketing Blog a “Must Read”
- Pharma Marketing Network 2007 Report
- Pharma Marketing Network Survey Results
- Pharma Marketing Stuck in Web 1.5
- Pharma’s Confidence Crisis: A Call for a New Marketing Paradigm?
- Pharma’s Plodding Approach to eMarketing
- Pharma’s Black Knight Confesses All!
- Pharma Marketing Roundtable – Members Only!
- Pharma McCarthyism
- Pharma Online Spending
- Pharma, Physicians, and Sermo
- Pharma SmartPhone/Tablet Apps: Is There a Regulation for That?
- Pharma’s Social Media Working Group
- Pharma Trends to Watch in 2006
- Pharmaceutical Competitive Intelligence
- Pharmaceutical Compliance with Fair Information Practice Principles
- Pharmaceutical Market Access 2010: Strategic Developments Impacting the US, EU, and Emerging Markets
- Pharmaceutical Marketing in Texas: look out for state privacy laws!
- The Pharmaguy Next Door
- Pharmaguy’s Twitter Followers: What Do They Want and How Is It Relevant to You?
- Pharmacy TeleStocking
- Pharma Marketers Dive Deeper Into Social Media: The Good, the Bad, & the Ugly Case Studies
- Up Front: Pharma’s 2010 Christmas Wish List for Santa
- Pharma’s Bad Rep or Bad Rap: Whatever! The Drug Industry Must Earn Back the Public’s Trust
- Pharma’s Image Conundrum: Building Brand Loyalty and Consumer Confidence
- Pharma’s Social Media Marketing Readiness Score
- Pharma-Sponsored Medical Ghostwriting: What the Ghosts Have to Say About It
- Up Front: Pharma Crisis Communications in the Fast-paced World of Twitter et al
- Pharma TeleWeb e-Detailing
- Pharma Twitter Pioneers Recognized
- The Pharmaguy Social Media Timeline™
- Phil Mickelson is Now Regulated by FDA
- PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing
- PhRMA Code Succeeding So Far
- PhRMA’s New Code on Interactions with Healthcare Professionals
- Physician Adoption and Use of Technology at the Point of Care
- Physicians Favor Brands With a Compelling Adherence Program
- Physician-Generated Content on Social Media Sites
- Physician Meetings: Education Works Both Ways
- Physicians Are Concerned That Pharma Supported CME is Biased, But …
- PR: Advertising by Other Means
- Predicting the Future of the Drug Industry
- Predictive Physician Marketing
- Up Front: Prepare or Die!
- Prescription Drugs and the Health 2.0 Opportunity
- The Price of Drugs
- A Primer on Pharma Employee Blogging
- Print DTC: How Does It Measure Up?
- Proactive e-Marketing Plan
- Product Branding, e-Marketing May Be Underutilized
- Product Web Sites: Are They Worth It?
- A Proposal for a Drug Risk Advisory System
- Protecting Your Brand with Anti-Counterfeiting Solutions
- Protection from Brand Infection: Marketers Must Take Control of Their Brands, Especially Online
- Provider/Pharmaceutical Partnerships – Are They Possible Without Conflict of Interest?
- Pushing the Envelope is Bad for DTC
- Putting the Customer Back in Customer Relationship Management
Q…
R…
- Ramifications of FDA Regulatory Actions: Helping FDA Find a New Media Regulatory Pathway
- Re-Designing the Pharma Sales Force
- Real Patient Testimonials
- Reforming the FDA: It All Starts with a New Commissioner!
- Reinventing the Sales Model
- Relationship Marketing via eNutrition
- Relationship Marketing Program Management for Pharmaceutical Marketers
- Relationships
- Rep Access Programs
- Report from the Social Pharmer “Unconference”: Sowing Seeds of Social Media Change?
- Reporting Gifts to Physicians
- Responding to the Challenges of Evolving Regulation
- Restrict DTC, but Extend the Patent for New Drugs
- Results from FDA Physician Survey on DTC Advertising
- Return on CME: Are Pharma Companies Getting Desired Outcomes?
- The Revitalized Brand: Creating a New Brand Image from an Old Product
- Risk Mitigation and Its Impact on Pharma Marketing: Appropriate Use Benefits After Launch
- The Role of Tablet PCs in Pharma Sales and Marketing
S…
- Sales Effectiveness Meets eMarketing
- Sales Force Effectiveness Metrics: More Important Than Ever in a Tough Market
- Sales Rep Assessment: Shoot the Messenger, the Message, or Both?
- Sales Reps Debate Their Value
- Scenarios on the Future of Pharma Marketing: No Time Like the Present to Think the Unthinkable
- Search Advertising Options for Pharma
- Searching for Answers on Search Engine Marketing?
- Separation of Church and State
- Should Bloggers Dine at Pharma’s Table?
- SiCKO is Boffo but Not Anti-Pharmaco Per Se
- Slides: The Currency of Communication
- Social Communications in Healthcare: Summary of Roundtable Discussions
- Social Media Adverse Event Reporting Safe Harbors: It’s Time for FDA to Open Up the Internet to Rx Advertising Like It Did with TV!
- Social Media and the Limitations of Disease Awareness Campaigns
- Social Media–Opportunity or Nightmare?
- Social Media & the Truncated News Pyramid
- Social Media Leaders Wanted
- Social Network Marketing: The Wisdom of the Crowd
- Socially Challenged Pharma: How Ready is Pharma to Engage In Social Media?>
- Society of Industry Leaders: Help for Investors
- Up Front: Solving the Adherence Problem in Economic Hard Times
- Solving the Social Media Adverse Event Reporting Problem
- Spam spam spam spam. Lovely spam! Wonderful spam!
- The State of CME in Europe
- Stop Wasting $Millions on Ineffective DTC Ads!
- Straight-Talking DTC Survey Results
- A Strategic Approach to CME Offers High Return on Education Investment
- Strategies for Enhanced Physician Targeting and Segmentation
- Strategies for Overcoming the Internal Challenges between Rx and OTC
- Super Bowl DTC Debut: Was It Good for You?
- Surfing the eMarketing Big One!
- Surveys Say…
- Surviving the Election Wars
- Up Front: Syndication is da Bomb!
T…
- Tailoring CRM Solutions to Your Business Strategy
- A Tale of Two Pharma Whistleblower Novels
- Targeted Faith-based Disease Awareness Marketing
- The Targeted Model: The Future of Pharmaceutical Marketing?
- Teaching New Dogs Old Tricks
- Texas Medical Privacy Act: A Wolf in Sheep’s Clothing?
- Thought-Leader Management: A Challenge Met
- Times They Are A-Changing?
- Tips for Improving Pharma Sales
- To Ban or Not to Ban DTC, That is the Question
- To Build Patient Adherence, Pfizer Puts Technology Behind The Curtain
- Top Companies, Classes, and Products in the DTC Space
- The Truth About the Drug Companies: What To Do About It
- Translate Industry Trends into the Optimal Promotional Strategy
- Transparency is the Word These Days
- Trends in Commercial Support of CME
- “Tribal Marketing”
- Turning Science into Sales
U…
- Understanding Drivers of Patient Behavior to Maximize DTC Effectiveness
- Understanding the Proposed ACCME Standards for Commercial Support
- Understanding the Strategic Value of MSLs
- Use of Behavioral Targeting by Pharma Marketers
- Use of Celebrities for PR and DTC Advertising
- Use of Social Media for Health Purposes in the EU
- Use of Twitter for Patient Support
V…
- Value-based Pricing
- The View From ePharma Summit: Practicing What Was Being Preached!
- Vioxx Withdrawal and the “Me-Too Drug Domino Effect”
W…
- Waiting for Goduidance (pdf)
- Waning Pharma Support of CME: The Plight of For-Profit MECCs
- Want to Know What Really Sucks?
- A Web-based Therapy Management Program
- Web 2.0 Pharma Marketing Tricks for Dummies
- What Americans Think About Drug Advertising
- What If There Were No Rules in Pharma Marketing?
- What Pharma Companies Spend on Gifts to Docs
- What Stands in the Way of the Mainstream Use of the Internet by Pharmaceutical Companies?
- What the Next Generation Physician Wants from Pharma
- What You Need to Know About the New “CAN-SPAM” Law
- What’s Next from the FDA?
- What’s Next vs. What’s Best
- Up Front: What’s Your Social Media Implementation Plan?
- When Is Commercial Support Appropriate for CME Activities?
- Who’s Better for Pharma: Obama or McCain?
- Whose Data Is It Anyway?
- Why Pharma Can’t Ignore eDetailers
- Why Pharmaceutical Marketers Ignore ROI
- Will COX-2 Inhibitors Crash and Burn?
- Will Healthcare be Rationed or Rational?: A Case for Supporting Comparative Effectiveness Research
- Will the Drug Industry be the Next Auto Industry?
- Whither CME?
- Whither Twitter for Pharma?
- Women in Pharma
- Word-of-Net
Y…
- You May Walk Like a Duck and Quack Like a Duck, But You’re No Duck!
- YouPharma: New Rules for Pharma Marketing and Social Media
- Your Pharma Marketing Sucks
Choose By Date of Publication
Click on a title to access the summary and from there you can view or order the full reprint.
2011
June 8, 2011 (Vol. 10, Issue #10)
Executive Summary of Complete Issue
- The Pharmaguy Social Media Timeline™
- Finding the Consumer Within the Patient
- New Facebook Policy “Kind of Hurts” Pharma Marketers
- FDA, DOJ, & Google: Conspiracy Theory, Part 2
- FDA Drops “Social Media” from Its 2011 Guidance Agenda
- First FDA Social Media Guidance to Address Responding to “Unsolicited Requests” for Off-label Information
May 18, 2011 (Vol. 10, Issue #9)
Executive Summary of Complete Issue
- Pharma SmartPhone/Tablet Apps: Is There a Regulation for That?
- Challenges of Regulating Mobile Medical Apps
- FDA’s BadAd Program Lacks Credible Evidence
- eDetailing Technology & Birth of “Sales Cyborg”
- Physicians Are Concerned That Pharma Supported CME is Biased, But …
- FDA v. Google & Those 14 Infamous Warning Letters
April 28, 2011 (Vol. 10, Issue #8)
Executive Summary of Complete Issue
- Physicians Favor Brands With a Compelling Adherence Program
- Implications of Facebook’s Page Commenting Changes
- A New Estimate of Drug Development Cost
- FDA Plans to Test New Standard for Easy to Understand Rx Labels
- FDA’s Bad Ad Program is “Phoniest Thing Ever!”
- Pharma Even More Digitally Feeble When it Comes to Healthcare Providers
April 15, 2011 (Vol. 10, Issue #7)
Executive Summary of Complete Issue
- The Changing Role of Pharma Sales Reps
- Mining Mobile Health App User Data
- (Little) Used Drug for Sale. GSK Says, Bye Bye Alli!
- Ad Dollars Follow Eyeballs to Web
- Phil Mickelson is Now Regulated by FDA
- Brits Beat FDA & PhRMA: Issue Social Media Guidance for Pharma
March 30, 2011 (Vol. 10, Issue #6)
Executive Summary of Complete Issue
- Adverse Event Reporting: A Missed Opportunity
- Pharma TeleWeb e-Detailing
- Physicians Favor Brands with Compelling Adherence Platform
- Are Sales Reps as “Useful” as PhRMA Wants Us to Believe?
- Astellas Scientist Shows How to Light Ice on Fire!
- FDA Promises Still More Guidance! This Time It’s Mobile.
March 10, 2011 (Vol. 10, Issue #5)
Executive Summary of Complete Issue
- Pharma Twitter Pioneers Recognized
- Evidence-Based Pharma Marketing
- Astrazeneca’s Twitter Survey: Will They Share Some Results?
- Method Acting for Real Patients Who Play Themselves on Pharma YouTube Channels
February 23, 2011 (Vol. 10, Issue #4)
Executive Summary of Complete Issue
- Will Critics Kill Pharma’s Social Media Golden Egg Laying Goose? (pdf)
- HCP Marketing Beyond the Physician: Plugging Into NPs and PAs
- Google’s New OneBox Rx “Ads” Steal Clicks from Organic Branded Rx Search Results
- OMG! AstraZeneca Hosts Twitter Chat & World Does NOT End!
- AstraZeneca Hosts “Take on Depression” Facebook Discussion – Seroquel Lurks Behind the Scenes
- Phil Mickelson “Opens Up” to Arthritis Today Magazine
February 17, 2011 (Vol. 10, Issue #3)
Executive Summary of Complete Issue
- Good Promotion Practices Alliance
- Breaking the 140-character Limit of Twitter Opens the Door to FDA-Compliant Branded Tweets
- FDA’s Abrams Spends 4 Minutes Discussing Social Media Guidance at ePharma Summit!
- The Socialisation of the Internet is Bogus
- GSK’s U.S. Sales Reps “Europeanized”: No Longer Rewarded for Ability to Push Prescriptions
January 19, 2011 (Vol. 10, Issue #2)
Executive Summary of Complete Issue
- Deal with Lack of Regulations by Developing Best Practices (pdf)
- Strategies for Marketing Compliance
- Getting Market Research Right in India & China
January 12, 2011 (Vol. 10, Issue #1)
Executive Summary of Complete Issue
- Welcome to the 2010 Pharma Marketing YearBook™
- Events I Witnessed, News You Made, & People We Met
- Pharma Social Media Trials & Tribulations
- Pharma Spending on Internet, DTC, and Docs
- Pharma Companies Behaving Badly
2010
December 2010 (Vol. 9, Issue #10)
Executive Summary of Complete Issue
- Up Front: Pharma’s 2010 Christmas Wish List for Santa
- New Media Privacy Issues & Online Health Marketing
- Pfizer’s Latest Lyrica DTC Ad Should Be Cited By FDA as Misleading
- Ad Execs Not Viewed as Innovative By Americans Says AstraZeneca Survey
- Pfizer’s Sales Reps Have 48 Hours to Out Deliver eSampling Program
November 2010 (Vol. 9, Issue #9)
Executive Summary of Complete Issue
- Up Front: Pharma Collaboration with Online Patient Opinion Leaders
- Physician-Generated Content on Social Media Sites
- Getting Market Research Right in the Middle East
- Capturing & Reporting HCP-Related Meeting Spending
October 2010 (Vol. 9, Issue #8)
Executive Summary of Complete Issue
- Up Front: Social Media and the Limitations of Disease Awareness Campaigns
- Integration of Custom Media into the Marketing Mix
- Digital Pharma Is Alive and Well in Europe!
- Getting Market Research Right in Emerging Markets
September 2010 (Vol. 9, Issue #7)
Executive Summary of Complete Issue
- Up Front: Solving the Adherence Problem in Economic Hard Times
- Pharma, Physicians, and Sermo
- Eyes on the Adherence Prize
- Closed-Loop Patient Education
Summer 2010 (Vol. 9, Issue #6)
Executive Summary of Complete Issue
- Up Front: Just-in-Time Publishing
- The iPad as a Pharma Marketing Platform
- Social Media Leaders Wanted
- The Pharmaguy Next Door
May 2010 (Vol. 9, Issue #5)
Executive Summary of Complete Issue
- Up Front: Pharma Crisis Communications in the Fast-paced World of Twitter et al
- The Changing Pharma Commercial Model in 2010 and Beyond
- ePrints NRx for Physician Detailing
- Data Mining in the Deep, Dark Social Networks of Patients
April 2010 (Vol. 9, Issue #4)
Executive Summary of Complete Issue
- Up Front: What’s Your Social Media Implementation Plan?
- Real Patient Testimonials
- How to Manage the Online Conversation
- Moderation Best Practices for Pharma Social Networks
- Use of Social Media for Health Purposes in the EU
March 2010 (Vol. 9, Issue #3)
Executive Summary of Complete Issue
- Up Front: FDA Can Relax. I Did All the Work for Them!
- Industry and Consumer Advocates Square Off Regarding Social Media
- Overcoming Space Limitations in Social Media
- Accountability for Pharma Content on Social Media Sites
- Solving the Social Media Adverse Event Reporting Problem
February 2010 (Vol. 9, Issue #2)
Executive Summary of Complete Issue
- Up Front: Waiting for Goduidance
- Use of Twitter for Patient Support
- Building the “New” Pharma Physician Marketing Model
- Pharma’s Social Media Working Group
- Use of Behavioral Targeting by Pharma Marketers
January 2010 (Vol. 9, Issue #1)
Executive Summary of Complete Issue
- Up Front: Healthcare Communications vs. Pharma Marketing
- Predicting the Future of the Drug Industry
- Corporate Reputation in the New Media World
- Pharma Begins to Reveal Payments to Physicians
2009
November/December 2009 (Vol. 8, Issue #10)
Executive Summary of Complete Issue
- Up Front: What’s Next from the FDA?
- Consequences of Direct-to-Consumer Advertising
- Search Advertising Options for Pharma
- A Few Things I Learned at FDA’s Social Media Hearing
- Pharma’s Image Conundrum: Building Brand Loyalty and Consumer Confidence
October 2009 (Vol. 8, Issue #9)
Executive Summary of Complete Issue
- Up Front: Fear and Loathing in Washington, DC
- Social Media Adverse Event Reporting Safe Harbors: It’s Time for FDA to Open Up the Internet to Rx Advertising Like It Did with TV!
- Pharmaceutical Market Access 2010: Strategic Developments Impacting the US, EU, and Emerging Markets
- Risk Mitigation and Its Impact on Pharma Marketing: Appropriate Use Benefits After Launch
September 2009 (Vol. 8, Issue #8)
Executive Summary of Complete Issue
- Up Front: Let’s Respond to FDA’s Questions Regarding Its Regulation of Social Media
- What If There Were No Rules in Pharma Marketing?: Be Sure Not to Cut Off the Ends of Your Ham
- Pharma-Sponsored Medical Ghostwriting: What the Ghosts Have to Say About It
- Pharmaguy’s Twitter Followers: What Do They Want and How Is It Relevant to You?
August 2009 (Vol. 8, Issue #7)
Executive Summary of Complete Issue
- Up Front: Social Media & the Truncated News Pyramid
- Owning the Prescription Pad: Driving Brand Decisions in a Multi-Influence World
- Social Communications in Healthcare: Summary of Roundtable Discussions
- Waning Pharma Support of CME: The Plight of For-Profit MECCs
June/July 2009 (Vol. 8, Issue #6)
Executive Summary of Complete Issue
- Up Front: Whither Twitter for Pharma?
- Pharma Marketers Dive Deeper Into Social Media: The Good, the Bad, & the Ugly Case Studies
- How Should Pharma Engage in Social Networks?: Thoughts on Best Practices
- FDA Draft Guidance on Risk: Reading the Tea Leaves
May 2009 (Vol. 8, Issue #5)
Executive Summary of Complete Issue
- Up Front: Will the Drug Industry be the Next Auto Industry?
- Protection from Brand Infection: Marketers Must Take Control of Their Brands, Especially Online
- Ramifications of FDA Regulatory Actions: Helping FDA Find a New Media Regulatory Pathway
- The New PhRMA Code and Beyond: Federal & State Laws are Eclipsing Self-Regulation
- From Nalty to “Nalts”: The Transformation of a Pharma Marketing Director into a “Viral Video Genius”
April 2009 (Vol. 8, Issue #4)
Executive Summary of Complete Issue
- Up Front: Social Media–Opportunity or Nightmare?
- Developing Guidelines for Pharma’s Use of the Internet & Social Media: A Call for a Public Hearing at FDA
- The Empowered Patient: What It Means for Pharma Marketers
- Socially Challenged Pharma: How Ready is Pharma to Engage In Social Media?
- Report from the Social Pharmer “Unconference”: Sowing Seeds of Social Media Change?
March 2009 (Vol. 8, Issue #3)
Executive Summary of Complete Issue
- Up Front: Syndication is da Bomb!
- Pharma’s Bad Rep or Bad Rap: Whatever! The Drug Industry Must Earn Back the Public’s Trust
- Will Healthcare be Rationed or Rational?: A Case for Supporting Comparative Effectiveness Research
- FDA’s Use of Social Media: Peanuts Today, Drugs Tomorrow!
- New Privacy Rules in Economic Stimulus Law: Will They Restrict Certain Pharmaceutical Marketing Practices?
February 2009 (Vol. 8, Issue #2)
Executive Summary of Complete Issue
- Up Front: My Pledge to Subscribers & Advertisers
- The View From ePharma Summit: Practicing What Was Being Preached!
- Building the Optimal Service Model: Creating the Right Physician Experiences to Drive Business
- The New Rules of Marketing & PR: Book Review and Insights for Pharma
- Sales Force Effectiveness Metrics: More Important Than Ever in a Tough Market
January 2009 (Vol. 8, Issue #1)
Executive Summary of Complete Issue
- Up Front: Is There Life After Pharma?
- The Future of DTC Advertising: Is a Perfect Storm Brewing?
- The ePharma Pioneer Club™: Convincing Pharma Marketers to Engage in “e”
- FDA Finalizes Guidance on Distribution of Reprints
- The Hypocrisy of Healthcare Marketing Restrictions: Stand Up for Healthcare Marketing Free Speech
2008
December 2008 (Vol. 7, Issue #10)
Executive Summary of Complete Issue
- Up Front: Prepare or Die!
- The Changing Policy Landscape: Prepare Now for the Coming FDA and Pharmaceutical Marketing Reforms
- Patient Assistance Program Rankings: Going Beyond Sales Force Effectiveness to Customer Experience Satisfaction
- Critical: What Daschle Plans to Do About the Healthcare Crisis
- Reforming the FDA: It All Starts with a New Commissioner!
November 2008 (Vol. 7, Issue #9)
Executive Summary of Complete Issue
- Up Front: Time for a New & Improved FDA Commissioner
- Free Drug Samples: The Sales Rep’s Last Great Hope?
- Optimizing Market Access: A Guide to Effective Pricing, Reimbursement and Messaging Strategies
- Measuring & Communicating eSuccess: Strategy First, YouTube Later… Maybe
October 2008 (Vol. 7, Issue #8)
Executive Summary of Complete Issue
- Up Front: Good Luck to Us All!
- Obama v. McCain Survey Results
- Medical Device Marketing
- Global Pharma Competitive Intelligence
- The State of CME in Europe
- Turning Science into Sales
September 2008 (Vol. 7, Issue #7)
Executive Summary of Complete Issue
- Up Front: Who’s Better for Pharma: Obama or McCain?
- PhRMA’s New Code on Interactions with Healthcare Professionals
- Building Power Sales Messages
- Current Issues and Future Prospects for Sales Force Effectiveness
- India’s Booming Pharmaceutical Market
June/July 2008 (Vol. 7, Issue #6)
Executive Summary of Complete Issue
- Up Front: Going Global, Networking Reception Highlights, Vendor Video Showcase
- Why Pharmaceutical Marketers Ignore ROI
- Creating the Most Effective Sales Calls
- Diversity in the Life Sciences
- Value-based Pricing
May 2008 (Vol. 7, Issue #5)
Executive Summary of Complete Issue
- Moving the Needle on Adherence
- High Impact Content in Support of Rx Brands
- How to Get Your Message In Front of Pharma Brand Managers
April 2008 (Vol. 7, Issue #4)
Executive Summary of Complete Issue
- DTC Risk Communication
- Building a Blockbuster
- Guerilla Pharma Marketing
- Reporting Gifts to Physicians
March 2008 (Vol. 7, Issue #3)
Executive Summary of Complete Issue
- I’m All a Twitter Over Twitter
- The Coming Pharma Marketing Recession
- Tips for Improving Pharma Sales
- What Americans Think About Drug Advertising
- Closed Loop Marketing
- Pharma’s Social Media Marketing Readiness Score
February 2008 (Vol. 7, Issue #2)
Executive Summary of Complete Issue
- Jarvik: A Modern DTC Tragedy
- FDA’s Good Reprint Practices Guidance
- Helping Pharma eMarketing “Grow up”
- Understanding the Strategic Value of MSLs
- Prescription Drugs and the Health 2.0 Opportunity
January 2008 (Vol. 7, Issue #1)
Executive Summary of Complete Issue
- DTC User Fees Go PDUffft!
- Use of Celebrities for PR and DTC Advertising
- Pharma Marketing Network 2007 Report
- Wither CME?
- Is It Time to End Industry Sponsored CME?
- Cholesterol Drug Users Discuss Their Medication
2007
November/December 2007 (Vol. 6, Issue #10)
- Diversity in Pharma
- Mapping New Paths through the DTC Marketing Mix Maze
- Accomplishing Adherence
- Medical Transcript Advertising
- Pharma Marketing Roundtable – Members Only!
- New Social Media Regulatory Framework
October 2007 (Vol. 6, Issue #9)
- Awards. What Are They Good For?
- Collaborating with Online Physician Communities
- Rep Access Programs
- Re-Designing the Pharma Sales Force
- Pharmaceutical Competitive Intelligence
September 2007 (Vol. 6, Issue #8)
- DTC, for Better or Worse, is Here to Stay
- Surviving the Election Wars
- Web 2.0 Pharma Marketing Tricks for Dummies
- Measuring Consumer Sentiment About Prescription Drugs
- Pharma Marketing Stuck in Web 1.5
July/August 2007 (Vol. 6, Issue #7)
- J&J’s PR Hindenburg Disaster!
- Merck Rejiggers Its Marketing Mix
- Stop Wasting $Millions on Ineffective DTC Ads!
- The Changing Landscape of Physician Interactions
- A Tale of Two Pharma Whistleblower Novels
June 2007 (Vol. 6, Issue #6)
- One…uh, Two Small Steps for Pharmaco Blogging!
- SiCKO is Boffo but Not Anti-Pharmaco Per Se
- Big Pharma Sales Analytics for the Rest of Us
- Got Game? Online Pharma Advergaming
- From Science to CEO: The Scientific Path to Corporate Leadership
May 2007 (Vol. 6, Issue #5)
- Moore: Please Don’t Ignore Us Pharma Bloggers
- Measuring an Intangible: Medical Science Liaison Metrics Consensus
- Optimizing Brand Equity: Pre-Launch through Patent Expiry and Beyond!
- Mobile Pharma Marketing: What’s the 411?
- Murky Physician Marketing and Education Practices
April 2007 (Vol. 6, Issue #4)
- Full Disclosure
- How Readable, Credible & Useful are Pharma Blogs?
- Targeted Faith-based Disease Awareness Marketing
- Americans Skeptical of Pharma Cause Marketing
- YouPharma: New Rules for Pharma Marketing and Social Media
- A Primer on Pharma Employee Blogging
March 2007 (Vol. 6, Issue #3)
- Should Bloggers Dine at Pharma’s Table?
- Disease Mongering: When Is the Line Crossed?
- Innerstate: The First Disease Awareness Documentary Film
- Are Pharma Bloggers Biased Against the Industry?
February 2007 (Vol. 6, Issue #2)
- God Bless R&D, but Marketers May Go to Hell!
- The Expanding Pharma Blogosphere
- Surfing the eMarketing Big One!
- Social Network Marketing: The Wisdom of the Crowd
- What’s Next vs. What’s Best
January 2007 (Vol. 6, Issue #1)
- Word-of-Net
- Are Sales Reps Necessary?
- Reinventing the Sales Model
- Sales Reps Debate Their Value
- An Online Community to Call Our Own
2006
November/December 2006 (Vol. 5, Issue #10)
- Betting the Pharm
- Congress vs. Pharma: Trouble Ahead?
- Pharma’s Plodding Approach to eMarketing
- Sales Effectiveness Meets eMarketing
- Teaching New Dogs Old Tricks
October 2006 (Vol. 5, Issue #9)
- Interpretation of Ads
- e-Inertia Plagues the Pharma Industry
- Optimizing DTC Performance
- The Brand Marketing Mix
- Pharma Online Spending
September 2006 (Vol. 5, Issue #8)
- Numbers
- Print DTC: How Does It Measure Up?
- Fast Start to Customized ePromotion and eLearning Physician Programs
- Pharma’s Black Knight Confesses All!
- Pharmacy TeleStocking
July/August 2006 (Vol. 5, Issue #7)
- Engagement
- PR: Advertising by Other Means
- Relationship Marketing via eNutrition
- Physician Meetings: Education Works Both Ways
- MSL Roles & Goals
June 2006 (Vol. 5, Issue #6)
- Could Chill Kill CME?
- Trends in Commercial Support of CME
- Slides: The Currency of Communication
- Free Prescription Drug Cards
- Whose Data Is It Anyway?
May 2006 (Vol. 5, Issue #5)
- Doing a Good Job but Still Not Trusted!
- The Changing World of MSLs: Determining Value
- Biotech DTC: Business Not As Usual
- Peter Rost: Whistle Blower, Pharma Blogger, ???
April 2006 (Vol. 5, Issue #4)
- Disease Mongering
- Communicating Risk: Let the Dialog Begin
- Merit of CHC Petition to FDA
- Managing Reprints for Better Clinical Support of Marketing
- The Electronic Formulary Will Change the Equation
March 2006 (Vol. 5, Issue #3)
- Buzz ‘n Blog Marketing
- The European eMarketing Scene: Desperately Seeking Strategy
- European Online Marketing Survey Results
- Effective Physician Marketing at Medical Meeting Exhibits
- Paid Inclusion: Too Hot for Pharma Marketing?
February 2006 (Vol. 5, Issue #2)
- Pharma McCarthyism
- Free Gifts to Physicians: What’s the Big Deal?
- What Pharma Companies Spend on Gifts to Docs
- Branded Physician Education: How to Integrate Promotion and Education
- Hard Sell: The Evolution of a Generation X Salesman
January 2006 (Vol. 5, Issue #1)
- The End of DTC as We Have Known It
- Pharma Trends to Watch in 2006
- Direct to Physician Telemarketing and Sales
- Pfizer France: Viva la SFE Difference!
- Women in Pharma
2005
December 2005 (Vol. 4, Issue #11)
- “Tribal Marketing”
- Blogs and the Pharmaceutical Industry
- DocCheck: Das Portal
- Generation Rx: A History and Critique of Pharma “Tribal Marketing”
November 2005 (Vol. 4, Issue #10)
- Pharma Marketing Blog a “Must Read”
- DTC Pros and Cons Presented at FDA Hearing
- Predictive Physician Marketing
- GSK Strikes Back with a Grassroots Campaign
- Global Digital Asset Brand Management
- Sales Rep Assessment: Shoot the Messenger, the Message, or Both?
October 2005 (Vol. 4, Issue #9)
- Surveys Say…
- eDetailing: Yesterday, Today and Tomorrow
- Managing Cross Boundary Issues
- Society of Industry Leaders: Help for Investors
- Mobile Medical Reference: An Effective Door Opener for Sales Reps
September 2005 (Vol. 4, Issue #8)
- It’s the Science, Stupid!
- cDetailing: Addressing the Consumer Education Gap
- The Evolving Impact of Anti-Spam Legislation on Online Marketers
- Patient Detailing at the Point of Care
- Midwestern eMarketing Values
July/August 2005 (Vol. 4, Issue #7)
- Restrict DTC, but Extend the Patent for New Drugs
- To Ban or Not to Ban DTC, That is the Question
- Marketing the Pharma Industry: The Empire Strikes Back
- Translate Industry Trends into the Optimal Promotional Strategy
- A Call to Action: A Mea Non Culpa by Big Pharma
June 2005 (Vol. 4, Issue #6)
- Transparency is the Word These Days
- Compliance with (Some) New ACCME Rules Not So Easy
- Protecting Your Brand with Anti-Counterfeiting Solutions
- Limbic Market Research: Plumbing the Subconscious Motivators of Physicians
- Drug Risk Survey Results
- A Strategic Approach to CME Offers High Return on Education Investment
- Pharma BloggoSphere Update
May 2005 (Vol. 4, Issue #5)
- A Good Time Was Had by All
- A Proposal for a Drug Risk Advisory System
- Thought-Leader Management: A Challenge Met
- Marketing in the Post-Vioxx Era
- Return on CME: Are Pharma Companies Getting Desired Outcomes?
- Is Pharma Marketing a Lot of BS?
April 2005 (Vol. 4, Issue #4)
- Separation of Church and State
- E-mail Marketing Best Practices for Pharma
- Measuring Marketing Strategy
- Beyond the eDetail: Evolving to Educate
- Growing Pharmaceutical Sales Utilizing Six Sigma and Lean
- Survey Results: Straight-Talking DTC
March 2005 (Vol. 4, Issue #3)
- Give Docs What They Want
- Marketing’s Role in Limiting Physician Access and What to Do About It
- Increase Prescription Sales with Smart Tools
- How to Sell a Drug Before it is Approved
- Leverage Health Beliefs to Develop Effective Online Compliance Programs
- Applying FDA Marketing Regulations to Internet Promotions
- Cost-Cutting Strategies for the Pharma Industry
February 2005 (Vol. 4, Issue #2)
- Times They Are A-Changing?
- You May Walk Like a Duck and Quack Like a Duck, But You’re No Duck!
- Relationship Marketing Program Management for Pharmaceutical Marketers
- DTC in 2005: Can You Teach Old Dogs New Tricks?
- Numbers, Math and Communicating Risk
- Does the FDA Need to be Overhauled?
January 2005 (Vol. 4, Issue #1)
- Blogging My Way Into 2005!
- Can Health Web Sites Improve Compliance?
- Facilitating Physician Access and Education Through Online Conferencing
- MSL Role in Educational Development
- Motivating & Retaining The MSL: What Makes MSLs Tick
- Managing Medical Science Liaisons From Afar
- A Web-based Therapy Management Program
- Drug Prices, Declining Profits Top Issues for 2005
2004
November/December 2004 (Vol. 3, Issue #10)
- Corporate “Moral Values” Anyone?
- The Truth About the Drug Companies: What To Do About It
- Creating a Successful DTC Campaign on the Inside
- A Novel Approach to Communicating with Physicians
- Is Your Product Ready for Consumers?
- Will COX-2 Inhibitors Crash and Burn?
October 2004 (Vol. 3, Issue #9)
- Vioxx Withdrawal and the “Me-Too Drug Domino Effect”
- Physician Adoption and Use of Technology at the Point of Care
- The Role of Tablet PCs in Pharma Sales and Marketing
- Strategies for Enhanced Physician Targeting and Segmentation
- No More Free Lunch in California?
- Drug Reimportation Survey Results
September 2004 (Vol. 3, Issue #8)
- Drug Importation Crisis: Terror Politics to the Rescue!
- The Indian Pharmaceutical Market
- Congress Fiddles While Reimportation Issue Burns
- Becoming Woman Wise: Marketing Healthcare to Women
- Accelerating Your Multicultural Communications
- How Cheap are Canada’s Drugs Really?
July/August 2004 (Vol. 3, Issue #7)
- The Price of Drugs
- California’s Physician Prescribing Act: A History of Twists and Turns
- A Crisis in Professional Detailing
- The Targeted Model: The Future of Pharmaceutical Marketing?
June 2004 (Vol. 3, Issue #6)
- Pharma eMarketing: A Level Playing Field or a Killing Field?
- Ready or Not: Gearing Up for the Expansion of ePrescribing
- ePrescribing: What Role Should Pharma Play?
- eDetailing Strategies for a Higher Physician Response
- The New Branding Model: From Blockbusters to Targeted Therapies
- Are ED Ads Too Sexually Explicit?
May 2004 (Vol. 3, Issue #5)
- Pushing the Envelope is Bad for DTC
- Searching for Answers on Search Engine Marketing?
- European Compliance Not Only Possible, But Leading Edge
- The Revitalized Brand: Creating a New Brand Image from an Old Product
- Branding as a Management Tool in Pharma
- Direct-To-Consumer Advertising: Developing Evidence-Based Policy To Improve Retention And Comprehension
April 2004 (Vol. 3, Issue #4)
- The Future of Big Pharma
- Intelligent Online Sampling Strategies
- The Internet and CME
- When Is Commercial Support Appropriate for CME Activities?
- Emotions, Focus and Storytelling: How Cialis is Challenging Viagra
- Maximizing the DTC Message: Healthcare Businesswomen’s Association Members Evaluate DTC Marketing
March 2004 (Vol. 3, Issue #3)
- Want to Know What Really Sucks?
- Scenarios on the Future of Pharma Marketing: No Time Like the Present to Think the Unthinkable
- Medical Science Liaisons: Working between Two Worlds
- Effective Pharma Adherence Programs Start With The Patient
- To Build Patient Adherence, Pfizer Puts Technology Behind The Curtain
- Your Pharma Marketing Sucks
- The New Written Prescription: Leveraging Technology to Measure Change in Physician Behavior as it Occurs
February 2004 (Vol. 3, Issue #2)
- Is DTC Educational or Motivational?
- Key Issues Facing DTC Marketers in 2004
- Beyond Patient Education: Influencing Behavior Change
- FDA Draft Guidance for Print DTCA: Less than Feared
- Super Bowl DTC Debut: Was It Good for You?
- Beyond DTC: Consumer Relationship Satisfaction
January 2004 (Vol. 3, Issue #1)
- Controlling Your Brand’s Switch Destiny
- Finding the “Right Stuff” to Revitalize Sales Productivity
- Spam spam spam spam. Lovely spam! Wonderful spam!
- Strategies for Overcoming the Internal Challenges between Rx and OTC
- What You Need to Know About the New “CAN-SPAM” Law
2003
December 2003 (Vol. 2, Issue #11)
- The FTC-Lilly Consent Decree: What it Means for PHARMA Vendors and Partners
- Guidelines for Off-label Communications
- Integrating Compliance into Commercial Practices
- Managing Privacy Risks in Your Commercial Practices
- PhRMA Code Succeeding…So Far
- Pharma’s Confidence Crisis: A Call for a New Marketing Paradigm?
November 2003 (Vol. 2, Issue #10)
- Balancing Idealistic vs. Realistic CRM Processes
- Developing Win-Win Key Opinion Leader Relationships
- Putting the Customer Back in Customer Relationship Management
- Relationships
- Tailoring CRM Solutions to Your Business Strategy
October 2003 (Vol. 2, Issue #9)
- The Future of eDetailing
- The Impact of eDetailing: Will it Complement, Replace, or Become Integrated with the Sales Force?
- Optimizing eDetailing ROI
- Why Pharma Can’t Ignore eDetailers
September 2003 (Vol. 2, Issue #8)
- Branding Internally: Think Brand, Not Product
- Evolve Your Brand into a Relationship with Consumers and Physicians
- What the Next Generation Physician Wants from Pharma
July 2003 (Vol. 2, Issue #7)
- Out-of-the-Box Marketing: Will It Work for Pharma?
- Patient-Level Data: A New Level of Analysis
- Understanding Drivers of Patient Behavior to Maximize DTC Effectiveness
June 2003 (Vol. 2, Issue #6)
- It’s All About Education
- Online CME – A Glass Half-Full or Half-Empty?
- Provider/Pharmaceutical Partnerships – Are They Possible Without Conflict of Interest?
- Responding to the Challenges of Evolving Regulation
- Understanding the Proposed ACCME Standards for Commercial Support
May 2003 (Vol. 2, Issue #5)
- Drug Marketers Need More Than Demographic Data To Effectively Market To Consumers
- Ethical Online Practices Build Consumer Trust
- Pharmaceutical Marketing in Texas: look out for state privacy laws!
- Proactive e-Marketing Plan
- Product Branding, e-Marketing May Be Underutilized
April 2003 (Vol. 2, Issue #4)
- e-Marketing at the Point of Care
- Pharma Marketing Network Survey Results
- PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing
March 2003 (Vol. 2, Issue #3)
- Consumer Use of the Internet for Health: Whose Numbers Do You Believe?
- Integrating Online & Offline Marketing: Challenges for Pharma
February 2003 (Vol. 2, Issue #2)
January 2003 (Vol. 2, Issue #1)
- Has DTC Spending Peaked?
- Online and Offline Professional and Consumer Marketing
- Results from FDA Physician Survey on DTC Advertising
- Top Companies, Classes, and Products in the DTC Space
2002
November 2002 (Vol. 1, Issue #9)
October 2002 (Vol. 1, Issue #8)
- Personalized e-Marketing – How can you create and profit from a customer’s lifetime experience?
- What Stands in the Way of the Mainstream Use of the Internet by Pharmaceutical Companies?
September 2002 (Vol. 1, Issue #7)
- The Absolute, Relative, and Incremental ROI of DTC e-Marketing
- Product Web Sites: Are They Worth It?
February 2002 (Vol. 1, Issue #2)
